| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
30 companies
Sandell Scott D is a 10% Owner at Savara Inc with holdings across 30 companies. Recent SEC Form 4 filings include 5 buys and 21 sells.
Estimated insider holdings value: $1567.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | KRRO Korro Bio, Inc. | 10% Owner | Buy | 207,100 | $11.11 | $2,300,881.00 | +19.0% | - | - | |
| Feb 9, 2026 | SGP Spyglass Pharma, Inc. | 10% Owner | Buy | 937,500 | $16.00 | $15,000,000.00 | +18.4% | - | - | |
| Oct 2, 2025 | NEUE Neuehealth, Inc. | Director, 10% Owner | Sale+OE | 4,195 | $6.75 | $28,316.25 | - | - | - | |
| Sep 16, 2024 | MBX Mbx Biosciences, Inc. | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +16.1% | -11.6% | -55.0% | |
| Apr 22, 2024 | KRRO Korro Bio, Inc. | 10% Owner | Buy | 17,857 | $56.00 | $999,992.00 | +1.7% | -29.2% | -76.1% | |
| Nov 20, 2023 | Director | Sell | 211,534 | $73.17 | $15,477,311.88 | -33.8% | +34.6% | +32.4% | ||
| Aug 8, 2023 | Director | Sell | 20,307 | $65.26 | $1,325,157.73 | -36.7% | -5.2% | +14.7% | ||
| Jul 17, 2023 | SVRA Savara Inc | 10% Owner | Buy | 333,333 | $3.00 | $999,999.00 | +1.4% | +11.8% | +58.0% | |
| Jan 26, 2023 | CBIO Crescent Biopharma, Inc. | 10% Owner | Sell | 3,652,016 | $3.14 | $11,484,515.02 | -22.0% | -59.1% | -5.1% | |
| Jan 5, 2023 | CBIO Crescent Biopharma, Inc. | 10% Owner | Sell | 71,362 | $2.76 | $196,859.21 | -0.8% | -53.1% | +7.7% |